A Rapid, Low-risk Approach for Process Transfer of Biologics from Development to Manufacturing Scale

This poster highlights a scaling methodology from the Ambr®️ 15 Cell Culture to the Biostat STR®️ 2000L without affecting the process or product quality. Using this scale-up approach, bioprocess scientists can develop faster, more cost-effective cell culture processes for their biologics manufacturing.

Complete Form to Access the File